NTC for Covid-19 emergency: our commitment is playing an active role to support community and raising awareness

  • Apr 30, 2020

The  Covid-19 situation has been evolving: the responsibility of everyone in implementing some essential measures, such as social distancing, personal hygiene and the use of protective equipment is fundamental to prevent Covid-19’s outbreak and approach safely our future social life.

NTC grants license and distribution rights in Mexico to Laboratorios Grin S.A. de C.V

  • Apr 21, 2020

Milan, April 21, 2020 – NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted license and distribution rights on one of its research and development products, a fixed combination in eye drops, in Mexico to Laboratorios Grin S.A. de C.V, a wholly owned affiliate of Lupin, focused on developing, manufacturing and distributing world-class medicines and a leader in the Ophthalmology segment. 

A three day intensive Action Agenda for NTC at CPhI 2019

  • Nov 5/7, 2019

CPhIWW represents for NTC an important event to create valuable long term business with partners from all over the world.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE